Clinical Trials
5
Active:3
Completed:0
Trial Phases
1 Phases
Phase 1:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
4 (100.0%)Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies
Phase 1
Terminated
- Conditions
- Non-hodgkin LymphomaHepatocellular CarcinomaBreast CancerAdenoid Cystic CarcinomaOsteosarcomaColorectal CancerGlomus Tumor, MalignantT-ALL
- Interventions
- First Posted Date
- 2018-02-06
- Last Posted Date
- 2024-01-16
- Lead Sponsor
- Cellestia Biotech AG
- Target Recruit Count
- 79
- Registration Number
- NCT03422679
- Locations
- 🇺🇸
Sarcoma Oncology Research Center, Santa Monica, California, United States
🇺🇸Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸MD Anderson, Houston, Texas, United States
News
No news found